Mahajan S, Atkins WM
Once daily injectable liraglutide (marketed as Victoza for T2DM and Saxenda for obesity) and once weekly injectable semaglutide (marketed as Ozempic for T2DM and Wegovy for obesity) are two additional GLP-1 analogues, sharing 97% and 94% amino acid homology to GLP-1, respectively [ Figure 2 , Table 1 ]
The 15 mg format allows researchers to maintain continuity across experiments that require repeated preparation or comparative analysis
Some patients may require laboratory testing before treatment, while others may not
Nestas condies, o medicamento se manter prprio para o consumo, respeitando o prazo de validade indicado na embalagem
Goud A, Zhong J, Peters M, Brook RD, Rajagopalan S